Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > AGN featured in The Power Play by The Market Herald

View:

Post by StockHawk1 on Jan 09, 2023 3:33pm

AGN featured in The Power Play by The Market Herald

The Power Play by The Market Herald just released this interview with Algernon Pharmaceuticals (AGN.c AGNPF) where they discuss their plans for a Phase 2b clinical study of their Ifenprodi drug for chronic cough.

The 180-patient 90-day study is set to start in Q3 of 2023.

The Phase 2a study already showed that Ifenprodil reduced cough counts in patients after 4 and 12 weeks, so I have high hopes for phase 2b.

AGN also plans to file an investigational new drug application shortly with the FDA. Great to see that AGN is quickly pushing forward with Ifenprodi.

https://themarketherald.ca/algernon-pharmaceuticals-announces-plans-for-a-180-patient-phase-2b-chronic-cough-study-of-ifenprodil-2023-01-09/

147